| PERIOD ENDING | 25-Sep-09 | 26-Jun-09 | 31-Mar-09 | 26-Dec-08 | | Total Revenue | 217,088 | 208,747 | 212,437 | 203,597 | | Cost of Revenue | 180,518 | 173,089 | 177,897 | 170,091 | | | Gross Profit | 36,570 | 35,658 | 34,540 | 33,506 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 13,400 | 14,092 | 13,011 | 13,220 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 2,852 | 2,830 | 3,007 | 2,803 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 20,318 | 18,736 | 18,522 | 17,483 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 22 | 40 | 6 | 17 | | Earnings Before Interest And Taxes | 20,340 | 18,776 | 18,528 | 17,500 | | Interest Expense | 898 | 1,147 | 1,256 | 1,970 | | Income Before Tax | 19,442 | 17,629 | 17,272 | 15,530 | | Income Tax Expense | 7,689 | 6,965 | 6,765 | 5,852 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 11,753 | 10,664 | 10,507 | 9,678 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 11,753 | 10,664 | 10,507 | 9,678 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $11,753 | $10,664 | $10,507 | $9,678 |
|
0.01% Nasdaq 0.00%
Income Statement
